Related references
Note: Only part of the references are listed.Decision-making based on sFlt-1/PlGF ratios: are immunoassay results interchangeable for diagnosis or prognosis of preeclampsia?
Guillaume Lefevre et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study
Akihide Ohkuchi et al.
HYPERTENSION RESEARCH (2021)
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia
Holger Stepan et al.
HYPERTENSION (2020)
Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4weeks and value of retesting
H. Zeisler et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women
Wei-zhen Lou et al.
DISEASE MARKERS (2019)
Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia
Xuming Bian et al.
HYPERTENSION (2019)
Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Holger Stepan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Randomized Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia INSPIRE
Ana Sofia Cerdeira et al.
HYPERTENSION (2019)
A study of the association between the sFlt-1/PIGF ratio and preeclampsia in Xinjiang Uygur Autonomous Region of China
Guifeng Ding et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Improving the Prediction of Preeclampsia
Ellen W. Seely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Harald Zeisler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Sociodemographic and obstetric characteristics of stillbirths in China: a census of nearly 4 million health facility births between 2012 and 2014
Jun Zhu et al.
LANCET GLOBAL HEALTH (2016)
Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China
J. Xiao et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Pre-eclampsia part 1: current understanding of its pathophysiology
Tinnakorn Chaiworapongsa et al.
NATURE REVIEWS NEPHROLOGY (2014)
The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP
A. L. Tranquilli et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2014)
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis
Cande V. Ananth et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
The Global Impact of Pre-eclampsia and Eclampsia
Lelia Duley
SEMINARS IN PERINATOLOGY (2009)
Changes in circulating level of angiogenic factors from first to second trimester as predictors of preeclampsia
Lars J. Vatten et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Management of pre-eclampsia
L Duley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Share Paper
